Epirubicin and antineoplasticsNo response: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1965卷 / 1期

关键词：

D O I：

10.1007/s40278-023-43168-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：200 / 200

相关论文

共 50 条

[21] AntineoplasticsNo therapeutic response: case report [J].

Reactions Weekly, 2022, 1914 (1) :71-71

[22] AntineoplasticsNo therapeutic response: case report [J].

Reactions Weekly, 2021, 1856 (1) :71-71

[23] AntineoplasticsNo therapeutic response: case report [J].

Reactions Weekly, 2022, 1937 (1) :66-66

[24] AntineoplasticsNo clinical response: case report [J].

Reactions Weekly, 2021, 1861 (1) :48-48

[25] AntineoplasticsNo response and acquired drug resistance: case report [J].

Reactions Weekly, 2023, 1953 (1) :57-57

[26] AntineoplasticsNo therapeutic response and various toxicities: case report [J].

Reactions Weekly, 2023, 1944 (1) :91-91

[27] AntineoplasticsNo improvement: case report [J].

Reactions Weekly, 2023, 1968 (1) :41-41

[28] AntineoplasticsNo response and B-cell aplasia: case report [J].

Reactions Weekly, 2023, 1942 (1) :40-40

[29] AntineoplasticsNo improvement: case report [J].

Reactions Weekly, 2022, 1917 (1) :82-82

[30] AntineoplasticsNo response and drug exposure during pregnancy: case report [J].

Reactions Weekly, 2022, 1901 (1) :75-75

← 1 2 3 4 5 →